Document:

<PAGE>   1

                                  EXHIBIT 4(d)

<PAGE>   2

                               SYMIX SYSTEMS, INC.

                      WARRANT FOR THE PURCHASE OF SHARES OF
                       COMMON STOCK OF SYMIX SYSTEMS, INC.

NO. 1-A                                                      WARRANT TO PURCHASE
                                                                  217,320 SHARES

         THIS WARRANT AND THE SECURITIES TO BE ACQUIRED UPON EXERCISE OF THIS
         WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
         AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD,
         TRANSFERRED, PLEDGED, HYPOTHECATED, ASSIGNED OR OTHERWISE DISPOSED OF
         EXCEPT IN COMPLIANCE THEREWITH. THIS WARRANT AND THE SECURITIES TO BE
         ACQUIRED UPON EXERCISE OF THIS WARRANT ALSO ARE SUBJECT TO ADDITIONAL
         RESTRICTIONS ON TRANSFER, VOTING AND OTHER MATTERS AS SET FORTH IN THE
         INVESTOR RIGHTS AGREEMENT (AS HEREIN DEFINED), COPIES OF WHICH MAY BE
         OBTAINED UPON WRITTEN REQUEST FROM THE COMPANY.

         FOR VALUE RECEIVED, SYMIX SYSTEMS, INC., an Ohio corporation (the
"COMPANY"), hereby certifies that MORGAN STANLEY DEAN WITTER VENTURE PARTNERS
IV, L.P., its successor or permitted assigns (the "HOLDER"), is entitled,
subject to the provisions of this Warrant (the "WARRANT"), to purchase from the
Company, at the times specified herein, up to an aggregate of 217,320 fully paid
and non-assessable Common Shares (as hereinafter defined), at a purchase price
per share equal to the Exercise Price (as hereinafter defined). The number of
Common Shares to be received upon the exercise of this Warrant and the price to
be paid for a Common Share are subject to adjustment from time to time as
hereinafter set forth. This Warrant and the Warrant Shares (as hereinafter
defined) may be assigned, transferred, sold, offered for sale or exercised by
the Holder only upon compliance with the terms and conditions hereof.

<PAGE>   3

           1.   Definitions.  (a) The following terms, as used herein, have the
following meanings:

         "AFFILIATE" shall have the meaning given to such term in Rule 12b-2
promulgated under the Securities and Exchange Act of 1934, as amended.

         "BUSINESS DAY" means any day except a Saturday, Sunday or other day on
which commercial banks in the City of New York are authorized by law to close.

         "COMMON SHARES" means the common shares, no par value, of the Company.

         "DULY ENDORSED" means duly endorsed in blank by the Person or Persons
in whose name a stock certificate is registered or accompanied by a duly
executed stock assignment separate from the certificate with the signature(s)
thereon guaranteed by a commercial bank or trust company or a member of a
national securities exchange or of the National Association of Securities
Dealers, Inc.

         "EXERCISE PRICE" means $15.00 per Warrant Share, such Exercise Price to
be adjusted from time to time as provided herein.

         "EXPIRATION DATE" means 5:00 p.m. New York City time on the fifth
anniversary of the date hereof.

         "INVESTOR RIGHTS AGREEMENT" means the Investor Rights Agreement dated
as of the date hereof among the Company and the shareholders listed on the
signature pages thereto.

         "PERSON" means an individual, partnership, limited liability company,
corporation, trust, joint stock company, association, joint venture, or any
other entity or organization, including a government or political subdivision or
an agency or instrumentality thereof.

         "HOLDERS" means the original Holders of the Warrants issued pursuant to
the Securities Purchase Agreement, or if any such original Holder so elects, any
transferee of all or any portion of this Warrant whom such original Holder shall
have designated by written notice to the Company. Any successor Holder
designated pursuant to the immediately preceding sentence shall also have the
right upon any subsequent transfer to designate a successor Holder in the manner
described above.

         "SECURITIES PURCHASE AGREEMENT" means the Securities Purchase Agreement
dated as of May 10, 2000 among the Company and the Investors listed

                                       2
<PAGE>   4

on the signature pages thereto, providing for the purchase and issuance of the
Series A Convertible Participating Preferred Stock and the Warrants.

         "WARRANT SHARES" means the shares of Common Stock deliverable upon
exercise of this Warrant, as adjusted from time to time.

          (b) Capitalized terms used but not defined herein shall have the
meanings assigned to such terms in the Investor Rights Agreement.

           2.   Exercise of Warrant.

          (a) Any sale, transfer, assignment or hypothecation of this Warrant,
whether in whole or in part, must be in compliance with Paragraph 12 of this
Warrant. Subject to the other terms and conditions of this Warrant, the Holder
is entitled to exercise this Warrant in whole or in part at any time, or from
time to time, until the Expiration Date or, if such day is not a Business Day,
then on the next succeeding day that shall be a Business Day. To exercise this
Warrant, the Holder shall execute and deliver to the Company a Warrant Exercise
Notice substantially in the form annexed hereto. Subject to paragraph 2(e)
below, no earlier than ten days after delivery of the Warrant Exercise Notice,
the Holder shall deliver to the Company this Warrant, including the Warrant
Exercise Subscription Form forming a part hereof duly executed by the Holder,
together with payment of the applicable Exercise Price. Upon such delivery and
payment, the Holder shall be deemed to be the holder of record of the Warrant
Shares subject to such exercise, notwithstanding that the stock transfer books
of the Company shall then be closed or that certificates representing such
Warrant Shares shall not then be actually delivered to the Holder.

          (b) The Exercise Price may be paid by wire transfer or by certified or
official bank check or bank cashier's check payable to the order of the Company
or by any combination of such cash or check.

          (c) If the Holder exercises this Warrant in part, this Warrant shall
be surrendered by the Holder to the Company and a new Warrant of the same tenor
and for the unexercised number of Warrant Shares shall be executed by the
Company. The Company shall register the new Warrant in the name of the Holder or
in such name or names of its transferee pursuant to paragraph 6 hereof as may be
directed in writing by the Holder and deliver the new Warrant to the Person or
Persons entitled to receive the same.

          (d) Upon exercise or partial exercise and surrender of this Warrant in
conformity with the foregoing provisions, the Company shall transfer to the
Holder of this Warrant appropriate evidence of ownership of the Common Shares
or other securities or property (including any money) to which the Holder is

                                       3
<PAGE>   5

entitled, registered or otherwise placed in, or payable to the order of, the
name or names of the Holder or such transferee as may be directed in writing by
the Holder, and shall deliver such evidence of ownership and any other
securities or property (including any money) to the Person or Persons entitled
to receive the same, together with an amount in cash in lieu of any fraction of
a share as provided in paragraph 5 below.

          (e) In lieu of exercising the Warrant pursuant to paragraph 2(a), the
Holder may elect in accordance with the procedures set forth in this paragraph 2
to exchange this Warrant for shares of Common Stock, in which event the Company
will issue to the Holder the number of shares of Common Stock equal to the
result obtained by (a) subtracting B from A, (b) multiplying the difference by
C, and (c) dividing the product by A as set forth in the following equation:

                  X = (A - B) x C where:
                           A

                           X  =     the number of shares of Common Stock
                                    issuable upon exchange pursuant to this
                                    paragraph 2(e).

                           A  =     the Daily Price (as defined below) on the
                                    day immediately preceding the date on which
                                    the Holder delivers written notice to the
                                    Company pursuant to paragraph 2(a).

                           B  =     the Exercise Price.

                           C  =     the number of shares of Common Stock as to
                                    which this Warrant being exchanged would
                                    other be exercisable for pursuant to
                                    paragraph 2(a).

         If the foregoing calculation results in a negative number, then no
shares of Common Stock shall be issued pursuant to this paragraph 2(e).

         (f) Mandatory Exercise. (i) If at any time after the second anniversary
of the date of issuance of this Warrant the Daily Price for a Common Share for
each and every day of any period of 40 consecutive trading days exceeds $24,
then this Warrant shall be automatically exercised on a net issuance basis in
accordance with paragraph (e) above at the Exercise Price, as adjusted, then in
effect as of the close of business on the last trading day of the 40 trading day
period (a "MANDATORY EXERCISE EVENT") into Common Shares (or other securities or
property into which this Warrant is then convertible). This Warrant as so
exercised shall be treated as having been surrendered by the Holder thereof for

                                       4
<PAGE>   6

exercise pursuant to Section 2 as of the close of business on the last trading
day of the 40 trading day period.

         (ii) If the Company shall at any time after the date of issuance of
this Warrant pay any dividend on Common Shares payable in Common Shares or
effect a subdivision or combination of the outstanding Common Shares (by
reclassification, stock split or otherwise) into a greater or lesser number of
Common Shares, then the share price referred to in clause (i) above shall be
adjusted upon the earlier of the public announcement or the occurrence of any
such event by multiplying the share price by a fraction of which the numerator
is the number of Common Shares that were outstanding immediately prior to such
event and of which the denominator is the number of Common Shares outstanding
immediately after such event; provided, however, that if thereafter, and before
such dividend is paid or such subdivision or combination is effected, the
Company legally abandons its plan to pay such dividend or to effect such
subdivision or combination, then any adjustment made to such share price by
reason of such public announcement shall be reversed, and any subsequent
adjustments, based thereon, shall be recomputed.

           3. Restrictive Legend. Certificates representing Common Shares issued
pursuant to this Warrant shall bear a legend substantially in the form of the
legend set forth on the first page of this Warrant to the extent that and for so
long as such legend is required pursuant to the Investor Rights Agreement or
applicable law.

           4. Reservation of Shares. The Company hereby agrees that at all times
prior to the expiration hereof there shall be reserved for issuance and delivery
upon exercise or exchange of this Warrant such number of its authorized but
unissued Common Shares or other securities of the Company from time to time
issuable upon the full exercise of the then unexercised portion of this Warrant.
All such shares shall be duly authorized and, when issued upon such exercise or
exchange, shall be validly issued, fully paid and non-assessable, free and clear
of all liens, security interests, charges and other encumbrances or restrictions
on sale and free and clear of all preemptive rights, except to the extent set
forth in the Investor Rights Agreement and as may be required under applicable
law.

           5. Fractional Shares. No fractional shares or scrip representing
fractional shares shall be issued upon the exercise or exchange of this Warrant
and in lieu of delivery of any such fractional share upon any exercise hereof,
the Company shall pay to the Holder an amount in cash equal to such fraction
multiplied by the Current Market Price Per Common Share (as defined in paragraph
8(g)) at the date of such exercise or exchange.

           6.   Transfer or Assignment of Warrant.

                                       5
<PAGE>   7

          (a) This Warrant and all rights hereunder are not transferable by the
registered Holder hereof except to any Person who, prior to such transfer,
agrees in writing, in form and substance reasonably satisfactory to the Company,
to be bound by the terms of this Warrant and the Investor Rights Agreement in
accordance with the provisions hereof and thereof. Each Holder of this Warrant
by taking or holding the same, consents and agrees that the registered Holder
hereof may be treated by the Company and all other persons dealing with this
Warrant as the absolute owner hereof for any purpose and as the person entitled
to exercise the rights represented hereby.

          (b) Subject to compliance with the terms of this Warrant and the
Investor Rights Agreement, the Holder of this Warrant shall be entitled, without
obtaining the consent of the Company to assign and transfer this Warrant, at any
time in whole or from time to time in part, to any Person or Persons. Subject to
the preceding sentence, upon surrender of this Warrant to the Company, together
with the attached Warrant Assignment Form duly executed, the Company shall,
without charge, execute and deliver a new Warrant for the Common Shares assigned
in the Warrant Form Assignment in the name of the assignee or assignees named in
such instrument of assignment and, if the Holder's entire interest is not being
assigned, a new Warrant for the balance of the Common Shares for which this
Warrant is then exercisable which are not so assigned in the name of the Holder
and this Warrant shall promptly be canceled.

           7. Loss or Destruction of Warrant. Upon receipt by the Company of
evidence satisfactory to it (in the exercise of its reasonable discretion) of
the loss, theft, destruction or mutilation of this Warrant, and (in the case of
loss, theft or destruction) of reasonably satisfactory indemnification, and upon
surrender and cancellation of this Warrant, if mutilated, the Company shall
execute and deliver to the Holder a new Warrant of like tenor and date.

           8.   Anti-dilution Provisions.

         (a) In case the Company shall at any time after the date hereof (i)
declare a dividend or make a distribution on Common Shares payable in Common
Shares, (ii) subdivide or split the outstanding Common Shares, (iii) combine or
reclassify the outstanding Common Shares into a smaller number of shares, or
(iv) issue any shares of its capital stock in a reclassification of Common
Shares (including any such reclassification in connection with a consolidation
or merger in which the Company is the continuing corporation), the Exercise
Price in effect at the time of the record date for such dividend or distribution
or of the effective date of such subdivision, split, combination or
reclassification shall be proportionately adjusted so that, giving effect to
paragraph 8(i), the exercise of this Warrant after such time shall entitle the
Holder to receive the aggregate number of Common Shares or other securities of
the Company (or shares of any

                                       6
<PAGE>   8

security into which such Common Shares have been reclassified pursuant to clause
8(a)(iii) or 8(a)(iv) above) which, if this Warrant had been exercised
immediately prior to such time, the Holder would have owned upon such exercise
and been entitled to receive by virtue of such dividend, distribution,
subdivision, split, combination or reclassification. Such adjustment shall be
made successively whenever any event listed above shall occur.

          (b) In case the Company shall issue or sell any Common Shares (other
than Common Shares issued (i) upon exercise of the Warrants or conversion of the
Series A Convertible Participating Preferred Shares of the Company (the
"PREFERRED SHARES"), (ii) pursuant to the Company's stock option plans or
pursuant to any similar Common Share related employee compensation plan of the
Company approved by the Company's Board of Directors or (iii) upon exercise or
conversion of any security the issuance of which caused an adjustment under
paragraphs 8(c) or 8(d) hereof) without consideration or for a consideration per
share less than the Exercise Price (the "ISSUE PRICE"), the Exercise Price to be
in effect after such issuance or sale shall be determined by multiplying the
Exercise Price in effect immediately prior to such issuance or sale by a
fraction, the numerator of which shall be the sum of (x) the number of Common
Shares outstanding immediately prior to the time of such issuance or sale
multiplied by the Issue Price and (y) the aggregate consideration, if any, to be
received by the Company upon such issuance or sale, and the denominator of which
shall be the product of the aggregate number of Common Shares outstanding
immediately after such issuance or sale and the Exercise Price. In case any
portion of the consideration to be received by the Company shall be in a form
other than cash, the fair market value of such noncash consideration shall be
utilized in the foregoing computation. Such fair market value shall be
determined by the Board of Directors of the Company; provided that if the
Holders of 75% of the outstanding Warrants shall object to any such
determination, the Board of Directors shall retain an independent appraiser
reasonably satisfactory to a majority of such Holders to determine such fair
market value. The Holder shall be notified promptly of any consideration other
than cash to be received by the Company and furnished with a description of the
consideration and the fair market value thereof, as determined by the Board of
Directors.

         (c) In case the Company shall fix a record date for the issuance of
rights, options or warrants to the holders of its Common Shares or other
securities entitling such holders to subscribe for or purchase for a period
expiring within 60 days of such record date Common Shares (or securities
convertible into Common Shares) at a price per Common Share (or having a
conversion price per Common Share, if a security convertible into Common Shares)
less than the Exercise Price on such record date, the maximum number of Common
Shares issuable upon exercise of such rights, options or warrants (or conversion
of such convertible securities) shall be deemed to have been issued and
outstanding as of such record

                                       7
<PAGE>   9

date and the Exercise Price shall be adjusted pursuant to paragraph 8(b) hereof,
as though such maximum number of Common Shares had been so issued for an
aggregate consideration payable by the holders of such rights, options, warrants
or convertible securities prior to their receipt of such Common Shares. In case
any portion of such consideration shall be in a form other than cash, the fair
market value of such noncash consideration shall be determined as set forth in
paragraph 8(b) hereof. Such adjustment shall be made successively whenever such
record date is fixed; and in the event that such rights, options or warrants are
not so issued or expire unexercised, or in the event of a change in the number
of Common Shares to which the holders of such rights, options or warrants are
entitled (other than pursuant to adjustment provisions therein comparable to
those contained in this paragraph 8), the Exercise Price shall again be adjusted
to be the Exercise Price which would then be in effect if such record date had
not been fixed, in the former event, or the Exercise Price which would then be
in effect if such holder had initially been entitled to such changed number of
Common Shares, in the latter event.

         (d) In case the Company shall issue rights, options (other than options
issued pursuant to a plan described in clause 8(b)(i)) or warrants entitling the
holders thereof to subscribe for or purchase Common Shares (or securities
convertible into Common Shares) or shall issue convertible securities (other
than the Preferred Shares), and the price per Common Share of such rights,
options, warrants or convertible securities (including, in the case of rights,
options or warrants, the price at which they may be exercised) is less than the
Exercise Price, the maximum number of Common Shares issuable upon exercise of
such rights, options or warrants or upon conversion of such convertible
securities shall be deemed to have been issued and outstanding as of the date of
such sale or issuance, and the Exercise Price shall be adjusted pursuant to
paragraph 8(b) hereof as though such maximum number of Common Shares had been so
issued for an aggregate consideration equal to the aggregate consideration
payable by the holders of such rights, options, warrants or convertible
securities prior to their receipt of such Common Shares. In case any portion of
such consideration shall be in a form other than cash, the fair market value of
such noncash consideration shall be determined as set forth in paragraph 8(b)
hereof. Such adjustment shall be made successively whenever such rights,
options, warrants or convertible securities are issued; and in the event that
such rights, options or warrants expire unexercised, or in the event of a change
in the number of Common Shares to which the holders of such rights, options,
warrants or convertible securities are entitled (other than pursuant to
adjustment provisions therein comparable to those contained in this paragraph
8), the Exercise Price shall again be adjusted to be the Exercise Price which
would then be in effect if such rights, options, warrants or convertible
securities had not been issued, in the former event, or the Exercise Price which
would then be in effect if such holders had initially been entitled to such
changed number of Common Shares, in the latter event. No adjustment of

                                       8
<PAGE>   10

the Exercise Price shall be made pursuant to this paragraph 8(d) to the extent
that the Exercise Price shall have been adjusted pursuant to paragraph 8(c) upon
the setting of any record date relating to such rights, options, warrants or
convertible securities and such adjustment fully reflects the number of Common
Shares to which the holders of such rights, options, warrants or convertible
securities are entitled and the price payable therefor.

          (e) In case the Company shall fix a record date for the making of a
dividend or distribution to holders of Common Shares (including any such
distribution made in connection with a consolidation or merger in which the
Company is the continuing corporation) of evidences of indebtedness, cash,
assets or other property (other than regular periodic dividends payable in cash
or Common Shares or rights, options or warrants referred to in, and for which an
adjustment is made pursuant to, paragraph 8(c) hereof), the Exercise Price to be
in effect after such record date shall be determined by multiplying the Exercise
Price in effect immediately prior to such record date by a fraction, the
numerator of which shall be the Current Market Price Per Common Share on such
record date, less the fair market value (determined as set forth in paragraph
8(b) hereof) of the portion of the assets, other property or evidence of
indebtedness so to be distributed which is applicable to one Common Share, and
the denominator of which shall be such Current Market Price Per Common Share.
Such adjustments shall be made successively whenever such a record date is
fixed; and in the event that such distribution is not so made, the Exercise
Price shall again be adjusted to be the Exercise Price which would then be in
effect if such record date had not been fixed.

          (f) If the average (weighted by daily trading volume) of the Daily
Prices (as defined below) per Common Share for the 40 consecutive trading days
immediately preceding the fourth anniversary of the date of issuance of the
Series A Preferred Shares (the "AVERAGE WEIGHTED PRICE") is less than $15.00
then the Exercise Price then in effect shall be reduced to the greater of (i)
the Average Weighted Price and (ii) 75% of the Exercise Price.

         (g) For the purpose of any computation under paragraph 5 or paragraph
8(b), 8(c), 8(d), 8(e) or 8(f) hereof, on any determination date the "CURRENT
MARKET PRICE PER COMMON SHARE" shall be deemed to be the average (weighted by
daily trading volume) of the Daily Prices (as defined below) per share of the
applicable class of Common Shares for the 20 consecutive trading days
immediately prior to such date. "DAILY PRICE" means (A) if such Common Shares
then are listed and traded on the New York Stock Exchange, Inc. ("NYSE"), the
closing price per share on such day as reported on the NYSE Composite
Transactions Tape; (B) if the shares of such class of Common Shares then are not
listed and traded on the NYSE, the closing price per share on such day as
reported

                                       9
<PAGE>   11

by the principal national securities exchange on which the shares are listed and
traded; (C) if such Common Shares then are not listed and traded on any such
securities exchange, the last reported sale price per share on such day on the
NASDAQ Stock Market; or (D) if such Common Shares then are not traded on the
NASDAQ Stock Market, the average of the highest reported bid and lowest reported
asked price per share on such day as reported by NASDAQ. If on any determination
date such Common Shares are not quoted by any such organization, the Current
Market Price Per Common Share shall be the fair market value of such shares on
such determination date as determined by the Board of Directors of the Company.
If the Holders of 75% of the outstanding Warrants shall object to any
determination by the Board of Directors of the Company of the Current Market
Price Per Common Share, the Current Market Price Per Common Share shall be the
fair market value per share of the Common Shares as determined by an independent
appraiser retained by the Company at its expense and reasonably acceptable to
such Holders. For purposes of any computation under this paragraph 8, the number
of shares of Common Shares outstanding at any given time shall not include
shares owned or held by or for the account of the Company.

          (h) All calculations under this paragraph 8 shall be made to the
nearest one tenth of a cent or to the nearest hundredth of a share, as the case
may be.

          (i) In the event that, at any time as a result of the provisions of
this paragraph 8, the holder of this Warrant upon subsequent exercise or
exchange shall become entitled to receive any shares of capital stock of the
Company other than Common Shares, the number of such other shares so receivable
upon exercise or exchange of this Warrant shall thereafter be subject to
adjustment from time to time in a manner and on terms as nearly equivalent as
practicable to the provisions contained herein.

          (j) Upon each adjustment of the Exercise Price as a result of the
calculations made in paragraphs 8(a), 8(b), 8(c), 8(d) or 8(e) hereof, the
number of shares for which this Warrant is exercisable immediately prior to the
making of such adjustment shall thereafter evidence the right to purchase, at
the adjusted Exercise Price, that number of Common Shares obtained by (i)
multiplying the number of shares covered by this Warrant immediately prior to
this adjustment of the number of shares by the Exercise Price in effect
immediately prior to such adjustment of the Exercise Price and (ii) dividing the
product so obtained by the Exercise Price in effect immediately after such
adjustment of the Exercise Price.

          (k) If the Company shall fix a record date relating to the payment of
a dividend or other distribution or the issuance of rights, options or warrants
as contemplated under this paragraph 8 (which results in an adjustment to the
Exercise Price under the terms of this Warrant) and shall thereafter, and before
such dividend or distribution is paid or delivered or before such issuance,
legally

                                       10
<PAGE>   12

abandon its plan to pay or deliver such dividend or distribution or to make such
issuance, then any adjustment made to the Exercise Price and number of Common
Shares purchasable upon exercise of this Warrant by reason of the fixing of such
record date shall be reversed, and any subsequent adjustments, based thereon,
shall be recomputed.

         9. Consolidation, Merger, or Sale of Assets. In case of any
consolidation of the Company with, or merger of the Company into, any other
Person, any merger of another Person into the Company (other than a merger which
does not result in any reclassification, conversion, exchange or cancellation of
outstanding Common Shares) or any sale or transfer of all or substantially all
of the assets of the Company or of the Person formed by such consolidation or
resulting from such merger or which acquires such assets, as the case may be,
the Holder shall have the right thereafter to exercise or exchange this Warrant
for the kind and amount of securities, cash and other property receivable upon
such consolidation, merger, sale or transfer by a holder of the number of Common
Shares for which this Warrant may have been exercised or exchanged immediately
prior to such consolidation, merger, sale or transfer, assuming (i) such holder
of Common Shares is not a Person with which the Company consolidated or into
which the Company merged or which merged into the Company or to which such sale
or transfer was made, as the case may be ("CONSTITUENT PERSON"), or an Affiliate
of a Constituent Person and (ii) in the case of a consolidation merger, sale or
transfer which includes an election as to the consideration to be received by
the holders, such holder of Common Shares failed to exercise such rights of
election, as to the kind or amount of securities, cash and other property
receivable upon such consolidation, merger, sale or transfer (provided that if
the kind or amount of securities, cash and other property receivable upon such
consolidation, merger, sale or transfer is not the same for each Common Share
held immediately prior to such consolidation, merger, sale or transfer by other
than a Constituent Person or an Affiliate thereof and in respect of which such
rights of election shall not have been exercised ("NON-ELECTING SHARE"), then
for the purpose of this paragraph 9 the kind and amount of securities, cash and
other property receivable upon such consolidation, merger, sale or transfer by
each non-electing share shall be deemed to be the kind and amount so receivable
per share by a plurality of the non-electing shares). Adjustments for events
subsequent to the effective date of such a consolidation, merger or sale of
assets shall be as nearly equivalent as may be practicable to the adjustments
provided for in this Warrant. In any such event, effective provisions shall be
made in the certificate or articles of incorporation of the resulting or
surviving corporation, in any contract of sale, conveyance, lease or transfer,
or otherwise so that the provisions set forth herein for the protection of the
rights of the Holder shall thereafter continue to be applicable; and any such
resulting or surviving corporation shall expressly assume the obligation to
deliver, upon exercise or exchange, such shares of stock, other securities, cash
and property.

                                       11
<PAGE>   13

The provisions of this paragraph 9 shall similarly apply to successive
consolidations, mergers, sales or transfers. For purposes of this paragraph 9,
"Person" shall not include any entity of which securities or other ownership
interests having ordinary voting power to elect a majority of the board of
directors or other persons performing similar functions are owned directly or
indirectly by the Company.

          10. Notices. Any notice, request, demand or delivery authorized by
this Warrant shall be in writing and shall be given to the Holder or the
Company, as the case may be, at its address (or telecopier number) set forth
below, or such other address (or telecopier number) as shall have been furnished
to the party giving or making such notice, demand or delivery in accordance
herewith:

         If to the Company:

                  Symix Systems, Inc.
                  2800 Corporate Exchange Drive
                  Columbus, Ohio 43231
                  Telecopy: (614) 895-2972
                  Attention: Corporate Counsel

         If to the Holder:

                  MSDW Venture Partners
                  1221 Avenue of the Americas
                  New York, New York 10020
                  Telecopy: 212-762-8424
                  Attention: Controller

Each such notice, request, demand or delivery shall be effective (i) if given by
telecopy, when such telecopy is transmitted to the telecopy number specified
herein and the intended recipient confirms the receipt of such telecopy or (ii)
if given by any other means, when received at the address specified herein.

         11. Rights of the Holder. Prior to the exercise or exchange of any
Warrant, the Holder shall not, by virtue hereof, be entitled to any rights of a
shareholder of the Company, including, without limitation, the right to vote, to
receive dividends or other distributions, to exercise any preemptive right or to
receive any notice of meetings of shareholders or any notice of any proceedings
of the Company except as may be specifically provided for herein.

         12. Transferee Representations. Prior to effecting any transfer of this
Warrant or any part hereof, each prospective transferee shall represent in
writing to the Company that:

                                       12
<PAGE>   14

          (a) Such transferee is an "accredited investor" within the meaning of
         Rule 501 under the 1933 Act and such transferee was not organized for
         the specific purpose of acquiring this Warrant or the Common Shares
         issuable upon exercise of this Warrant;

          (b) such transferee has sufficient knowledge and experience in
         investing in companies similar to the Company so as to be able to
         evaluate the risks and merits of such transferee's investment in the
         Company and is able financially to bear the risks thereof;

          (c) such transferee has had an opportunity to obtain whatever
         information concerning the Company and the Common Shares as has been
         requested from the Company by such transferee in order to make such
         transferee's investment decision with respect to this Warrant and the
         Common Shares;

          (d) this Warrant is being acquired by such transferee for such
         transferee's own account for the purpose of investment and not with a
         view to or for sale in connection with any distribution thereof; and

          (e) such transferee understands that (i) this Warrant and the Common
         Shares issuable upon exercise of this Warrant have not been registered
         under the Securities Act of 1933, as amended, in reliance upon an
         exemption from the registration requirements of such act pursuant to
         Section 4(2) thereof or Rule 506 promulgated under such act and under
         applicable state securities laws, (ii) this Warrant and the Common
         Shares issuable upon exercise of this Warrant must be held indefinitely
         unless a subsequent disposition thereof is registered under such act
         and under applicable state securities laws or is exempt from such
         registration, (iii) this Warrant and the Common Shares issuable upon
         exercise of this Warrant will bear a legend to such effect, and (iv)
         the Company will make a notation on its transfer books to such effect.

          13. GOVERNING LAW. THIS WARRANT AND ALL RIGHTS ARISING HEREUNDER SHALL
BE CONSTRUED AND DETERMINED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF
OHIO, AND THE PERFORMANCE THEREOF SHALL BE GOVERNED AND ENFORCED IN ACCORDANCE
WITH SUCH LAWS.

          14. Amendments; Waivers. Any provision of this Warrant may be amended
or waived if, and only if, such amendment or waiver is in writing and signed, in
the case of an amendment, by the Holder and the Company, or in the

                                       13
<PAGE>   15

case of a waiver, by the party against whom the waiver is to be effective. No
failure or delay by either party in exercising any right, power or privilege
hereunder shall operate as a waiver thereof nor shall any single or partial
exercise thereof preclude any other or further exercise thereof or the exercise
of any other right, power or privilege. The rights and remedies herein provided
shall be cumulative and not exclusive of any rights or remedies provided by law.

                                       14
<PAGE>   16

         IN WITNESS WHEREOF, the Company has duly caused this Warrant
Certificate to be signed by its duly authorized officer and to be dated as of
May 10, 2000.

                                            SYMIX SYSTEMS, INC.

                                            By:/s/ Lawrence DeLeon
                                               ---------------------------------
                                               Name: Lawrence DeLeon
                                               Title: CFO

Acknowledged and Agreed:

MORGAN STANLEY DEAN WITTER VENTURE PARTNERS IV, L.P.

By: MSDW Venture Partners IV, LLC,
    as general partner

By: MSDW Venture Partners IV, Inc.,
    as member

By: /s/Guy de Chazal
    ----------------------------
    Name: Guy de Chazal
    Title: Managing Director

                                       15
<PAGE>   17

                             WARRANT EXERCISE NOTICE

                (To be delivered prior to exercise of the Warrant
             by execution of the Warrant Exercise Subscription Form)

To:      Symix Systems, Inc.

         [ ] [The undersigned hereby notifies you of its intention to exercise
the warrant to purchase common shares, no par value, of Symix Systems, Inc. held
by the undersigned (the "WARRANT"). The undersigned intends to exercise the
Warrant to purchase ___________ common shares (the "SHARES") at $______ per
Share (the Exercise Price currently in effect pursuant to the Warrant). The
undersigned intends to pay the aggregate Exercise Price for the Shares, by wire
transfer, or certified or official bank or bank cashier's check (or a
combination of cash and check) as indicated below.]

         [The undersigned hereby notifies you of its intention to exchange the
Warrant on a cashless basis pursuant to Section 2(e) of the Warrant to purchase
Common Shares, no par value, of Symix Systems, Inc. Based on an exercise price
of $_______ per Share (the Exercise Price currently in effect pursuant to the
Warrant) and a Daily Price of $______, the undersigned intends to exchange the
Warrant for _________ Common Shares.]

Date:
     ----------------

                                  ----------------------------------------------
                                  (Signature of Holder)
                                  This signature must conform in all respects
                                  to the name of the Holder as specified on the
                                  Warrant

                                  ----------------------------------------------
                                  (Street Address)

                                  ----------------------------------------------
                                  (City)   (State)

Payment:  $                   wire transfer
           ------------------

          $                   check
           ------------------

                                       16
<PAGE>   18

                       WARRANT EXERCISE SUBSCRIPTION FORM

                (To be executed only upon exercise of the Warrant
                   after delivery of Warrant Exercise Notice)

To:      [Issuer]

         The undersigned irrevocably exercises this Warrant for the purchase of
___________ common shares, no par value (the "SHARES"), of Symix Systems, Inc.
(the "COMPANY") at $_____ per Share (the Exercise Price currently in effect
pursuant to the Warrant) and herewith makes payment of $___________ (such
payment being made by wire transfer or by certified or official bank or bank
cashier's check payable to the order of the Company or by any permitted
combination of such wire transfer or check), all on the terms and conditions
specified in the within Warrant, surrenders this Warrant and all right, title
and interest therein to the Company and directs that the Shares deliverable upon
the exercise of this Warrant be registered or placed in the name and at the
address specified below and delivered thereto.

Date:
     ------------------

                                 -----------------------------------------------
                                 (Signature of Holder)
                                 This signature must conform in all respects
                                 to the name of the Holder as specified on the
                                 Warrant

                                 -----------------------------------------------
                                 (Street Address)

                                 -----------------------------------------------
                                 (City)              (State)          (Zip Code)

<PAGE>   19

Securities and/or check to be issued to:
                                        ----------------------------------------

Please insert social security or identifying number:
                                                    ----------------------------

Name:
     ---------------------------------------------------------------------------

Street Address:
               -----------------------------------------------------------------

City, State and Zip Code:
                         -------------------------------------------------------

Any unexercised portion of the Warrant evidenced by the within Warrant
Certificate to be issued to:

Please insert social security or identifying number:
                                                    ----------------------------

Name:
     ---------------------------------------------------------------------------

Street Address:
               -----------------------------------------------------------------

City, State and Zip Code:
                         -------------------------------------------------------

                                       2
<PAGE>   20

                             WARRANT ASSIGNMENT FORM

                                                      Dated _____________, 200__

         FOR VALUE RECEIVED, _______________________ hereby

         irrevocably sells,  assigns and transfers

         unto_____________________________(the "ASSIGNEE"),

                    (please type or print in block letters)

________________________________________________________________________________
                                (insert address)

its right to purchase up to ___________ common shares, without par value, of
Symix Systems, Inc. (the "COMPANY") represented by this Warrant and does hereby
irrevocably constitute and appoint _______________________ Attorney, to transfer
the same on the books of the Company, with full power of substitution in the
premises.

                                Signature:
                                          -----------------------------------
                                          (Signature of Holder)
                                          This signature must conform in all
                                          respects to the name of the Holder as
                                          specified on the Warrant

<PAGE>   21
                                   SCHEDULE A
                                   TO WARRANT

         The following investors entered into warrants for the purchase of the
number of common shares, no par value, of Symix Systems, Inc., set forth next to
their respective names. The warrants are identical to the warrant of Morgan
Stanley Dean Witter Venture Partners IV, L.P., set forth in Exhibit 4(d) of
this Quarterly Report on Form 10-Q, except with respect to the number of common
shares, no par value, of Symix Systems, Inc. covered by the respective warrants.

Investor                                                        Number of Shares
--------                                                        ----------------

Morgan Stanley Dean Witter Venture Investors IV, L.P.                25,212

Morgan Stanley Dean Witter Venture Offshore Investors IV, L.P.        8,478

Morgan Stanley Dean Witter Equity Funding, Inc.                      69,202

Fallen Angel Equity Fund, L.P.                                      133,334<PAGE>   1
                                 EXHIBIT 10(a)

<PAGE>   2

                          SECURITIES PURCHASE AGREEMENT

                            dated as of May 10, 2000

                                     between

                               SYMIX SYSTEMS, INC.

                                       and

                           THE INVESTORS NAMED HEREIN

<PAGE>   3

                                TABLE OF CONTENTS

                             ----------------------
<TABLE>
<CAPTION>

                                                                                             PAGE
                                                                                             ----
<S>                                                                                          <C>
                                            ARTICLE I
                                           DEFINITIONS

SECTION 1.01.  Definitions......................................................................1

                                           ARTICLE II
                                        PURCHASE AND SALE

SECTION 2.01.  Purchase and Sale................................................................4
SECTION 2.02.  Closing..........................................................................5

                                           ARTICLE III
                          REPRESENTATIONS AND WARRANTIES OF THE COMPANY

SECTION 3.01.  Corporate Existence and Power....................................................5
SECTION 3.02.  Corporate Authorization..........................................................6
SECTION 3.03.  Governmental Authorization; Consents.............................................6
SECTION 3.04.  Non-contravention................................................................7
SECTION 3.05.  Capitalization...................................................................7
SECTION 3.06.  SEC Filings......................................................................7
SECTION 3.07.  Financial Statements.............................................................8
SECTION 3.08.  Absence of Certain Changes.......................................................9
SECTION 3.09.  Litigation......................................................................10
SECTION 3.10.  Compliance with Contracts.......................................................10
SECTION 3.11.  Erisa Representations...........................................................11
SECTION 3.12.  Tax Representations.............................................................12
SECTION 3.13.  Insurance Coverage..............................................................13
SECTION 3.14.  Compliance with Laws............................................................13
SECTION 3.15.  Transactions with Affiliates....................................................14
SECTION 3.16.  Finders' Fees...................................................................14
SECTION 3.17.  Antitakeover Statutes...........................................................14

                                           ARTICLE IV
                           REPRESENTATIONS AND WARRANTIES OF INVESTORS

SECTION 4.01.  Organization and Existence......................................................15
SECTION 4.02.  Authorization...................................................................15
SECTION 4.03.  Governmental Authorization......................................................15
SECTION 4.04.  Non-contravention...............................................................15
SECTION 4.05.  Finders' Fees...................................................................15
</TABLE>

<PAGE>   4

<TABLE>
<CAPTION>

                                                                                             PAGE
<S>                                                                                           <C>
SECTION 4.06.  Financing.......................................................................16
SECTION 4.07.  Purchase for Investment.........................................................16

                                            ARTICLE V
                                    COVENANTS OF THE COMPANY

SECTION 5.01.  Access to Information...........................................................16
SECTION 5.02.  Notices of Certain Events.......................................................17
SECTION 5.03.  Use of Proceeds.................................................................17
SECTION 5.04.  Corporate Governing Documents...................................................17
SECTION 5.05.  Restrictive Agreements Prohibited...............................................18
SECTION 5.06.  Voting Power....................................................................18
SECTION 5.07.  Additional Warrants.............................................................18

                                           ARTICLE VI
                                     COVENANTS OF INVESTORS

SECTION 6.01.  Notices of Certain Events.......................................................18
SECTION 6.02.  Confidentiality.................................................................19

                                           ARTICLE VII
                                    COVENANTS OF ALL PARTIES

SECTION 7.01.  Best Efforts....................................................................19
SECTION 7.02.  Certain Filings; NASDAQ listing.................................................20
SECTION 7.03.  Public Announcements............................................................20
SECTION 7.04.  Tax Consistency.................................................................20

                                          ARTICLE VIII
                                      CONDITIONS TO CLOSING

SECTION 8.01.  Conditions to the Obligations of Each Party.....................................20
SECTION 8.02.  Conditions to Obligation of Investors...........................................20
SECTION 8.03.  Conditions to Obligation of the Company.........................................21

                                           ARTICLE IX
                                            SURVIVAL

SECTION 9.01.  Survival........................................................................22
</TABLE>

                                       ii

<PAGE>   5

<TABLE>
<CAPTION>

<S>                                                                                           <C>
                                            ARTICLE X
                                           TERMINATION

SECTION 10.01.  Grounds for Termination........................................................22
SECTION 10.02.  Effect of Termination..........................................................22

                                           ARTICLE XI
                                          MISCELLANEOUS

SECTION 11.01.  Notices........................................................................23
SECTION 11.02.  Amendments; No Waivers.........................................................23
SECTION 11.03.  Expenses.......................................................................24
SECTION 11.04.  Successors and Assigns.........................................................24
SECTION 11.05.  Governing Law..................................................................24
SECTION 11.06.  Counterparts...................................................................24
SECTION 11.07.  Entire Agreement...............................................................24
SECTION 11.08.  Specific Performance...........................................................24
SECTION 11.09.  Captions.......................................................................25
</TABLE>

Exhibit A         Amendment to Amended Articles of Incorporation
Exhibit B         Investor Rights Agreement
Exhibit C         Warrant

                                      iii

<PAGE>   6

                          SECURITIES PURCHASE AGREEMENT

         AGREEMENT dated as of May 10, 2000 between Symix Systems, Inc., an Ohio
corporation (the "COMPANY"), and the several investors set forth on Schedule I
hereto (individually, an "INVESTOR" and collectively the "INVESTORS").

                              W I T N E S S E T H :

         WHEREAS, the Investors desire to purchase from the Company the
Securities (as hereinafter defined) and the Company desires to sell the
Securities to the Investors, upon the terms and subject to the conditions
hereinafter set forth;

         WHEREAS, the Investors and the Company desire to enter into certain
other agreements;

         NOW, THEREFORE, the parties hereto agree as follows:

                                    ARTICLE I
                                   DEFINITIONS

         SECTION 1.01. Definitions. (a) The following terms, as used herein,
have the following meanings:

         "AFFILIATE" means, with respect to any Person, any other Person
directly or indirectly controlling, controlled by, or under common control with,
such Person. For the purposes of this definition, "CONTROL" when used with
respect to any Person, means the possession, directly or indirectly, of the
power to direct or cause the direction of the management and policies of such
Person, whether through the ownership of voting securities, by contract or
otherwise; and the terms "CONTROLLING" and "CONTROLLED" have meanings
correlative to the foregoing.

         "AMENDMENT" means the amendment to the Amended Articles of
Incorporation of the Company, as amended, which designate and set forth the
preferences and rights of the holders of the Series A Preferred Shares,
substantially in the form attached hereto as Exhibit A.

         "BENEFICIAL OWNERSHIP" and "BENEFICIALLY OWN" shall be determined in
accordance with Rule 13d-3 under the 1934 Act.

         "BENEFIT ARRANGEMENT" means any employment, severance or similar
contract, arrangement or policy, or any plan or arrangement providing for
severance benefits, insurance coverage (including any self-insured
arrangements), workers' compensation, disability benefits, supplemental
unemployment benefits,

<PAGE>   7

vacation benefits, retirement benefits, deferred compensation, profit-sharing,
bonuses, stock options, stock appreciation rights or other forms of incentive
compensation or post-retirement insurance, compensation or benefits that (i) is
not an Employee Plan or Company Stock Plan or made pursuant to an Employee Plan
or Company Stock Plan, (ii) is entered into or maintained, as the case may be,
by the Company or any of its ERISA Affiliates, (iii) covers any employee or
former employee of the Company or any Subsidiary and (iv) involves an obligation
of the Company and/or the Subsidiaries to pay an aggregate amount in excess of
$200,000.

         "CLOSING DATE" means the date of the Closing.

         "CODE" means the Internal Revenue Code of 1986, as amended.

         "COMMISSION" means the United States Securities and Exchange
Commission.

         "COMMON SHARES" means the common shares, no par value, of the Company.

         "COMPANY STOCK PLANS" means any present or future Employee Plan,
employment agreement, restricted stock, stock option, stock purchase or dividend
reinvestment plan or other similar type of plan of the Company which provides
for the issuance of equity securities or options or rights to purchase equity
securities of the Company.

         "ENFORCEABILITY EXCEPTION" means the limitations which may be placed on
enforceability by bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance and other laws of general applicability relating to or affecting
creditors' rights and by general principles of equity.

         "ERISA" means the Employee Retirement Income Security Act of 1974, as
amended.

         "ERISA AFFILIATE" of any entity means any other entity which, together
with such entity, would be treated as a single employer under Section 414 of the
Code.

         "INVESTOR RIGHTS AGREEMENT" means the Investors Rights Agreement dated
as of the Closing Date among the Company, the Investors and Lawrence J. Fox,
substantially in the form of Exhibit B hereto.

         "LIEN" means, with respect to any asset, any mortgage, lien, pledge,
charge, security interest or encumbrance of any kind in respect of such asset.

                                       2
<PAGE>   8

         "MATERIAL ADVERSE CHANGE" means a material adverse change in the
business, assets, financial condition or results of operations of the Company
and the Subsidiaries, taken as a whole.

         "MATERIAL ADVERSE EFFECT" means a material adverse effect on the
business, assets, financial condition or results of operations of the Company
and the Subsidiaries, taken as a whole.

         "MULTIEMPLOYER PLAN" means a multiemployer plan, as defined in Section
3(37) of ERISA.

         "1933 ACT" means the Securities Act of 1933, as amended, and the rules
and regulations promulgated thereunder.

         "1934 ACT" means the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder.

         "PBGC" means the Pension Benefit Guaranty Corporation.

         "PERSON" means an individual, a corporation, a partnership, limited
liability company, an association, a trust or other entity or organization,
including a government or political subdivision or an agency or instrumentality
thereof.

         "SECURITIES" means the Shares and Warrants.

         "SERIES A PREFERRED SHARES" means the Series A Convertible
Participating Preferred Shares, no par value, of the Company.

         "SHARES" means 566,933 Series A Preferred Shares.

         "SUBSIDIARY" means any entity of which securities or other ownership
interests having ordinary voting power to elect a majority of the board of
directors or other persons performing similar functions are owned directly or
indirectly by the Company.

         "TAX" (and, with correlative meaning, "TAXES") shall include (i) any
net income, alternative or add-on minimum tax, gross income, gross receipts,
sales, use, ad valorem, value added, transfer, franchise, profits, license,
withholding on amounts paid to or by the Company or any Subsidiary, payroll,
employment, excise, severance, stamp, occupation, premium, property,
environmental or windfall profit tax, custom, duty or other tax, governmental
fee or other like assessment or charge of any kind whatsoever, together with any
interest or any penalty, addition to tax or additional amount due from, or in
respect of the Company or any subsidiary, as the case may be, imposed by any
federal, state,

                                       3
<PAGE>   9

local or foreign governmental authority (a "TAXING AUTHORITY") responsible for
the imposition of any such tax (domestic or foreign), (ii) any liability of the
Company or any Subsidiary for the payment of any amounts of the type described
in (i) as a result of being a member of an affiliated, consolidated, combined or
unitary group for any period and (iii) any liability of the Company or any
Subsidiary for the payment of any amount as a result of being a party to any tax
sharing agreement or with respect to the payment of any amount of the type
described in (i) as a result of any existing express or implied agreement or
arrangement (including, but not limited to, an indemnification agreement or
arrangement).

         "TITLE IV PLAN" means an employee benefit plan, other than any
Multiemployer Plan, subject to Title IV of ERISA.

         "TRANSACTION AGREEMENTS" means this Agreement and the Investor
Rights Agreement.

         "WARRANTS" means the warrants to purchase 453,546 Common Shares,
substantially in the form of Exhibit C hereto.

          (b)   Each of the following terms is defined in the Section set forth
opposite such term:

Term                                                       Section
----                                                       -------
Balance Sheet                                               3.07
Balance Sheet Date                                          3.07
Closing                                                     2.02
Company SEC Documents                                       3.06
Company 10-K                                                3.06
Company Securities                                          3.05
Employee Plans                                              3.11
GAAP                                                        3.07
Returns                                                     3.12

                                   ARTICLE II
                                PURCHASE AND SALE

         SECTION 2.01. Purchase and Sale. Upon the terms and subject to the
conditions of this Agreement, the Company agrees to sell to each Investor, and
each Investor severally agrees to purchase from the Company, the number of
Shares and Warrants at the aggregate prices set forth opposite the names of such

                                       4
<PAGE>   10

Investor on Schedule I hereto. The aggregate purchase price payable by the
Investors for all the Securities is $13,606,392 in cash.

         SECTION 2.02. Closing. The closing (the "CLOSING") of the purchase and
sale of the Securities hereunder shall take place at the offices of Davis Polk &
Wardwell in New York City as soon as possible, but in no event later than five
business days, after satisfaction of the conditions set forth in Article VIII,
or at such other time or place as the Investors and the Company may agree. At
the Closing,

          (a) each Investor shall transfer to the Company the applicable
purchase price payable by it in immediately available funds by wire transfer to
an account of the Company designated by the Company, by notice to the Investors,
no later than two business days prior to the Closing Date; and

          (b) the Company shall deliver to each Investor certificates for the
Securities being purchased by such Investor registered in the name of such
Investor.

                                   ARTICLE III
                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

         The Company hereby represents and warrants to each Investor that:

         SECTION 3.01. Corporate Existence and Power. (a) The Company is a
corporation duly incorporated, validly existing and in good standing under the
laws of its jurisdiction of incorporation, and has all corporate powers and all
material governmental licenses, authorizations, consents and approvals required
to carry on its business as now conducted, except where the failure to have such
governmental licenses, authorizations, consents and approvals would not,
individually or in the aggregate, have a Material Adverse Effect. The Company is
duly qualified to do business as a foreign corporation and is in good standing
in each jurisdiction where the character of the property owned or leased by it
or the nature of its activities make such qualification necessary, except for
those jurisdictions where failure to be so qualified would not, individually or
in the aggregate, have a Material Adverse Effect. The Company has heretofore
delivered to the Investors or their counsel true and complete copies of the
articles of incorporation and regulations of the Company as currently in effect.

          (b) Each of the Company's Subsidiaries which would qualify as a
"SIGNIFICANT SUBSIDIARY" pursuant to Regulation S-X under the 1933 Act, all of
which are listed in the Company 10-K, is a business corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction of its

                                       5
<PAGE>   11

incorporation, and has the corporate power and authority to own or lease its
properties and assets and to carry on its business as it is now being conducted,
except where the failure to have such governmental licenses, authorizations,
consents and approvals would not, individually or in the aggregate, reasonably
be expected to result in a Material Adverse Effect.

         SECTION 3.02. Corporate Authorization. (a) The execution, delivery and
performance by the Company of the Transaction Agreements and the Warrants and
the consummation by the Company of the transactions contemplated thereby are
within the Company's corporate powers and, except for corporate authorizations
and actions contemplated by this Agreement to occur subsequent to the date
hereof and prior to Closing, have been duly authorized by all necessary
corporate action on the part of the Company. This Agreement constitutes, and,
when executed by the parties thereto, the Investor Rights Agreement will
constitute, a valid and binding agreement of the Company, enforceable in
accordance with their respective terms, except as the indemnification obligation
of the Company under the Investor Rights Agreement may be limited by applicable
law and except for the Enforceability Exceptions.

          (b) The Warrants, when executed and delivered in accordance with the
terms of this Agreement, will constitute valid and binding obligations of the
Company.

          (c) The Shares, when issued and delivered to and paid for by each
Investor pursuant to this Agreement, will be validly issued, fully paid and
non-assessable, and such Shares are free of preemptive or similar rights except
as set forth in this Agreement. The Common Shares to be reserved for issuance
upon exercise of the Warrants or conversion of the Shares, as the case may be,
have been, or prior to the Closing will be, duly authorized by the Company and
reserved for issuance upon such exercise or conversion and, when issued upon
such exercise or conversion in accordance with the terms of the Warrants or the
Shares, as the case may be, will have been validly issued, fully paid and
non-assessable, and such Common Shares will be free of preemptive or similar
rights except as set forth in the Investor Rights Agreement.

         SECTION 3.03. Governmental Authorization; Consents. (a) The execution,
delivery and performance by the Company of the Transaction Agreements and the
Warrants require no action by or in respect of, or filing with, any governmental
body, agency, official or authority other than compliance with any applicable
requirements of the 1933 Act and applicable state securities laws.

          (b) No consent, approval, waiver or other action by any Person under
any contract, agreement, indenture, lease, instrument or other document to which
the Company or any Subsidiary is a party or by which any of them is bound is
required or necessary for the execution, delivery and performance of the

                                       6
<PAGE>   12

Transaction Agreements and the Warrants by the Company or the consummation by
the Company of the transactions contemplated thereby.

         SECTION 3.04. Non-contravention. The execution, delivery and
performance by the Company of the Transaction Agreements do not and will not (i)
contravene or conflict with the Amended Articles of Incorporation, as amended,
or the Amended Regulations, as amended, of the Company; (ii) assuming compliance
with the matters referred to in Section 3.03(a), contravene or conflict with or
constitute a violation of any provision of any law, regulation, judgment,
injunction, order or decree binding upon or applicable to the Company or any
Subsidiary; (iii) constitute a material default under or give rise to any right
of termination, cancellation or acceleration of any material right or obligation
of the Company or any Subsidiary or to a loss of any material benefit to which
the Company or any Subsidiary is entitled under any provision of any material
agreement, contract or other instrument binding upon the Company or any
Subsidiary or any license, franchise, permit or other similar authorization held
by the Company or any Subsidiary; or (iv) result in the creation or imposition
of any Lien on any asset of the Company or any Subsidiary, except, in the case
of those items specified in (ii) or (iv) above which would not, individually or
in the aggregate, result in a Material Adverse Effect.

         SECTION 3.05. Capitalization. The authorized capital stock of the
Company consists of 20,000,000 Common Shares and 1,000,000 preferred shares, no
par value. As of April 28, 2000, there were outstanding 7,503,657 Common Shares,
no preferred shares and employee stock options to purchase an aggregate of
1,925,547 Common Shares (of which, options to purchase an aggregate of 1,209,279
Common Shares were exercisable). All outstanding Common Shares have been duly
authorized and validly issued and are fully paid. Except (1) as set forth in
this Section 3.05, (2) for changes since April 28, 2000 resulting from the
exercise of employee stock options outstanding on such date and (3) for any
Company Stock Plans or securities issued pursuant thereto, there are no
outstanding (i) shares of capital stock or other voting securities of the
Company, (ii) securities of the Company convertible into or exchangeable for
shares of capital stock or voting securities of the Company or (iii) options or
other rights to acquire from the Company, and there is no obligation of the
Company to issue (other than any obligation that may arise under the Investor
Rights Agreement), any capital stock, voting securities or securities
convertible into or exchangeable for capital stock or voting securities of the
Company (the items in clauses (i), (ii) and (iii) being referred to collectively
as the "COMPANY SECURITIES"). Except as contemplated by the Transaction
Documents and the Company Stock Plans, there are no outstanding obligations of
the Company or any Subsidiary to issue or deliver or to repurchase, redeem or
otherwise acquire any Company securities.

         SECTION 3.06. SEC Filings. (a) The Company has delivered to each
Investor or its counsel (i) the Company's annual report on Form 10-K for its
fiscal

                                       7
<PAGE>   13

year ended June 30, 1999 (the "COMPANY 10-K"), (ii) its quarterly reports on
Form 10-Q for its fiscal quarters ended September 30, 1999 and December 31,
1999, respectively, (iii) its proxy or information statements relating to
meetings of, or actions taken without a meeting by, the shareholders of the
Company held since June 30, 1999, and (iv) all of its other reports, statements,
schedules and registration statements filed with the SEC since June 30, 1999
(the documents referred to in this Section 3.06(a), collectively, the "COMPANY
SEC DOCUMENTS").

          (b) As of its filing date, each Company SEC Document complied as to
form in all material respects with the applicable requirements of the 1933 Act
and the 1934 Act, as the case may be.

          (c) As of its filing date (or, if amended or superceded by a filing
prior to the date hereof, on the date of such filing), each Company SEC Document
filed pursuant to the 1934 Act did not, and each such Company SEC Document filed
subsequent to the date hereof will not, contain any untrue statement of a
material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were
made, not misleading.

          (d) Each Company SEC Document that is a registration statement, as
amended or supplemented, if applicable, filed pursuant to the 1933 Act, as of
the date such registration statement or amendment became effective, did not
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein
not misleading.

          (e) Since July 1, 1999, the Company and its Subsidiaries, as
applicable, have filed all reports, registrations and statements, together with
any amendments required to be made with respect thereto, that were required to
be filed with the Commission.

         SECTION 3.07. Financial Statements. (a) The audited consolidated
financial statements and unaudited consolidated interim financial statements of
the Company included in the Company SEC Documents fairly present, in conformity
with generally accepted accounting principles ("GAAP") applied on a consistent
basis (except as may be indicated in the notes thereto), the consolidated
financial position of the Company and its consolidated Subsidiaries as of the
dates thereof and their consolidated results of operations and cash flows for
the periods then ended (subject to normal year-end adjustments in the case of
any unaudited interim financial statements). For purposes of this Agreement,
"BALANCE SHEET" means the consolidated statements of condition of the Company
(and consolidated Subsidiaries) as of June 30, 1999 set forth in the Company
10-K and "BALANCE SHEET DATE" means June 30, 1999.

                                       8
<PAGE>   14

          (b) Absence of Undisclosed Liabilities. Other than liabilities
disclosed, or provided for, in the Company SEC Documents, (i) there are no
liabilities of the Company or the Subsidiaries of any kind whatsoever, whether
accrued, contingent, absolute, determined, determinable or otherwise, and (ii)
there is no existing condition, situation or set of circumstances which would
result in such a liability, except in the case of each of clauses (i) and (ii)
for liabilities that, individually or in the aggregate, have not had and would
not reasonably be expected to have a Material Adverse Effect.

         SECTION 3.08. Absence of Certain Changes. Since the Balance Sheet Date,
other than as disclosed, or provided for, in the Company SEC Documents, the
Company and the Subsidiaries have conducted their businesses in the ordinary
course and there has not been:

          (a) any Material Adverse Change or any event, occurrence, development
or state of circumstances or facts which would reasonably be expected to result
in a Material Adverse Change, other than those relating to the economy generally
and regulatory changes;

          (b) (i) any declaration, setting aside or payment of any dividend or
other distribution with respect to any shares of capital stock of the Company,
or (ii) any repurchase, redemption or other acquisition by the Company or any
Subsidiary of any outstanding shares of capital stock or other securities of, or
other ownership interests in, the Company or any Subsidiary except in connection
with (x) the internal corporate reorganization of the Company and the
Subsidiaries initiated in October 1999, (y) the acquisition of all outstanding
capital stock of Frontstep, Inc. (f/k/a Profit Solutions, Incorporated) by the
Company in January, 2000 and (z) the acquisition of brightwhite solutions, inc.
capital stock by Frontstep, Inc. in February, 2000;

          (c)   any amendment of any material term of any outstanding equity
security of the Company;

          (d) any (i) grant of any material severance or termination pay to (or
amendment to any existing arrangement with) any director, officer or employee of
the Company or any of its Subsidiaries, (ii) material increase in benefits
payable under any existing severance or termination pay policies or employment
agreements, (iii) entering into any employment, deferred compensation or other
similar agreement (or any amendment to any such existing agreement) with any
director, officer or employee of the Company or any of the Subsidiaries, except
employment agreements entered into in connection with the acquisition of Profit
Solutions, Incorporated (n/k/a Frontstep, Inc.) in January, 2000 and the
acquisition of the assets of Infomentum, Ltd. in February, 2000, other than in
the ordinary course of business consistent with past practice; (iv)
establishment, adoption or amendment (except as required by applicable law) of
any collective bargaining,

                                       9
<PAGE>   15

bonus, profit-sharing, thrift, pension, retirement, deferred compensation,
compensation, stock option, restricted stock or other benefit plan or
arrangement covering any director, officer or employee of the Company or any of
its Subsidiaries, other than in the ordinary course of business consistent with
past practice, or (v) increase in compensation, bonus or other benefits payable
to any director, officer or employee of the Company or any of its Subsidiaries,
other than in the ordinary course of business consistent with past practice;

          (e) any damage, destruction or other casualty loss (whether or not
covered by insurance) affecting the business or assets of the Company or any
Subsidiary which, individually or in the aggregate, has had or would reasonably
be expected to have a Material Adverse Effect after giving effect to insurance;
or

          (f) any loss of a customer, client or business partner that,
individually or in aggregate, would be material to the business or financial
condition of the Company and its Subsidiaries, taken as a whole; or

          (g) any change in any method of accounting or accounting practice by
the Company or any Subsidiary, except for any such change after the date hereof
required by reason of a concurrent change in or application of generally
accepted accounting principles.

         SECTION 3.09. Litigation. Except as set forth in the Company SEC
Documents filed prior to the date hereof, there is no action, suit,
investigation or proceeding (or any basis therefor) pending against, or, to the
knowledge of the Company, threatened against or affecting, the Company, any of
the Subsidiaries, any present or former officer, director or employee of the
Company or any of the Subsidiaries or any Person for whom the Company or any
Subsidiary may be liable or any of their respective properties before any court
or arbitrator or before or by any governmental body, agency or official,
domestic, foreign or supranational, that, if determined or resolved adversely in
accordance with the plaintiff's demands, would reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect or that in any
manner challenges or seeks to prevent, enjoin, alter or materially delay any of
the transactions contemplated hereby.

         SECTION 3.10. Compliance with Contracts. Neither the Company nor any
Subsidiary is in default under, and no condition exists that with notice or
lapse of time or both would constitute a default under, (i) any mortgage, loan
agreement, indenture or evidence of indebtedness for borrowed money to which the
Company or any Subsidiary is a party or by which the Company or any Subsidiary
or any material amount of their assets is bound or (ii) any judgment, order or
injunction of any court, arbitrator or governmental body, agency, official or
authority which defaults or potential defaults under either clauses (i) or (ii),
individually or in the aggregate, would reasonably be expected to have a
Material Adverse Effect.

                                       10
<PAGE>   16

         SECTION 3.11. Erisa Representations. (a) Schedule 3.11 sets forth each
"employee benefit plan", as defined in Section 3(3) of ERISA, that (i) is
subject to any provision of ERISA, (ii) is maintained, administered or
contributed to by the Company or any of its ERISA Affiliates and (iii) covers
any employee or former employee of the Company or any Subsidiary. Such plans are
hereinafter referred to as the "EMPLOYEE PLANS". The Company has furnished or
made available to the Investors or their counsel copies of such plans (and, if
applicable, related trust agreements) and all amendments thereto and written
interpretations thereof together with the most recent annual report prepared in
connection with any such plan (Form 5500 including, if applicable, Schedule B
thereto). No Employee Plan is and neither the Company nor any of its ERISA
Affiliates maintains, sponsors, or is obligated to contributed to, or has at any
time maintained, sponsored or been obligated to contribute to, a Multiemployer
Plan, a Title IV Plan or an employee benefit plan or arrangement maintained in
connection with any trust described in Section 501(c)(9) of the Code.

          (b) No "prohibited transaction", as defined in Section 406 of ERISA or
Section 4975 of the Code, has occurred with respect to any Employee Plan
excluding transactions effected pursuant to a statutory or administrative
exemption, which, assuming the taxable period of such transaction expired as of
the date hereof, when considered individually or in the aggregate with any other
such prohibited transaction, could subject the Company or any of its
Subsidiaries to a penalty or tax imposed by either Section 502(i) of ERISA or
Section 4975 of the Code in an amount which would be material.

          (c) Each Employee Plan that is intended to be qualified under Section
401(a) of the Code is so qualified and has been so qualified during the period
from its adoption to date, and each trust created under any such Employee Plan
is exempt from tax under Section 501(a) of the Code and has been so exempt
during the period from creation to date. The Company has provided the Investors
or their counsel with the most recent determination letters of the Internal
Revenue Service relating to each such Employee Plan. Each Employee Plan has been
maintained in substantial compliance with its terms and with the requirements
prescribed by any and all applicable statutes, orders, rules and regulations,
including but not limited to ERISA and the Code.

          (d) Schedule 3.11 sets forth each Benefit Arrangement. The Company has
furnished or made available to the Investors or their counsel copies or
descriptions of each Benefit Arrangement. Each Benefit Arrangement has been
maintained in substantial compliance with its terms and with the requirements
prescribed by any and all applicable statutes, orders, rules and regulations.

          (e) Neither the Company nor any of its ERISA Affiliates has any
current or projected liability in respect of post-employment or post-retirement
welfare benefits for retired or former employees of the Company and any
Subsidiary,

                                       11
<PAGE>   17

except as required to avoid excise tax under Section 4980B of the Code or as
previously disclosed by the Company in writing to the Investors.

          (f) Except as disclosed in writing to the Investors prior to the date
hereof, there has been no amendment to, written interpretation of or
announcement (whether or not written) by the Company or any of its ERISA
Affiliates relating to, or change in employee participation or coverage under,
any Employee Plan or Benefit Arrangement that would increase materially the
expense of maintaining such Employee Plan or Benefit Arrangement above the level
of the expense incurred in respect thereof for the fiscal year ended prior to
the date hereof.

          (g) Except as set forth in Schedule 3.11, there is no contract,
agreement, plan or arrangement covering any employee or former employee of the
Company or any of its subsidiaries that, individually or collectively, could
give rise to the payment of any amount that would not be deductible pursuant to
the terms of Section 280G of the Code, except as previously disclosed by the
Company in writing to the Investors.

          (h) No material tax under Section 4980B of the Code has been incurred
in respect of any Employee Plan that is a group health plan, as defined in
Section 5000(b)(1) of the Code.

          (i) No employee or former employee of the Company or any of its ERISA
Affiliates will become entitled to any bonus, retirement, severance, job
security or similar benefit or enhancement of such a benefit solely as a result
of the transactions contemplated by this Agreement.

         SECTION 3.12. Tax Representations. Except for liabilities and penalties
which would not, individually or in the aggregate, reasonably be expected to
result in a Material Adverse Effect, (i) all Tax returns, statements, reports
and forms (including estimated tax returns and reports) required to be filed
with any Taxing Authority by or on behalf of the Company or any Subsidiary
(collectively, the "RETURNS"), have been or will be filed when due (taking into
account any extension of a required filing date) in accordance with all
applicable laws except where failure so to file would not subject the Company or
any Subsidiary to liabilities or penalties; (ii) as of the time of filing, the
Returns correctly reflected (and, as to any Returns not filed as of the date
hereof, will correctly reflect) the facts regarding the income, business,
assets, operations, activities and status of the Company, the Subsidiaries and
any other information required to be shown therein and complete in all material
respects; (iii) the Company and the Subsidiaries have timely paid, withheld or
made provision for all Taxes shown as due and payable on the Returns that have
been filed; (iv) the Company and the Subsidiaries have made or will on or before
the Closing Date make provision for all Taxes payable by the Company and the
Subsidiaries for any Tax period (or

                                       12
<PAGE>   18

portion thereof) ending on or before the Closing Date for which no Return has
yet been filed; (v) the charges, accruals and reserves for Taxes with respect to
the Company and its Subsidiaries for any Tax period (or portion thereof) ending
on or before the Closing Date (excluding any provision for deferred income
taxes) reflected on the books of the Company and the Subsidiaries are adequate
to cover such Taxes; (vi) all consolidated federal income tax Returns filed with
respect to taxable years of the Company and the Subsidiaries through the taxable
year ended June 30, 1996 have been examined and closed or are Returns with
respect to which the applicable period for assessment under applicable law,
after giving effect to extensions or waivers, has expired; (vii) neither the
Company nor any Subsidiary is delinquent in the payment of any Tax; (viii)
neither the Company nor any Subsidiary (or any member of any affiliated or
combined group of which the Company or any Subsidiary is or has been a member)
has granted any extension or waiver of the limitation period applicable to any
Returns; (ix) there is no claim, audit, action, suit, proceeding or
investigation now pending or threatened against or with respect to the Company
or any Subsidiary of which the Company is aware in respect of any Tax or
assessment; (x) there are no liens for Taxes upon the assets of the Company or
any Subsidiary except liens for current Taxes not yet due; (xi) neither the
Company nor any of its Subsidiaries has any obligation under any Tax sharing
agreement, Tax allocation agreement or Tax indemnity agreement or any other
agreement or arrangement in respect of any Tax with any Person other than the
Company or its Subsidiaries; (xii) neither the Company nor any of its
Subsidiaries has been a member of an affiliated, consolidated, combined or
unitary group other than one of which the Company was the common parent;; (xiii)
proper and adequate amounts have been withheld by the Company and its
Subsidiaries from their respective employees and other Persons for all periods
in compliance in all material respects with the Tax, social security and
unemployment, excise and other withholding provisions of all federal, state,
local and foreign laws; and (xiv) the Company is not now and has not been within
the past five years, a "United States Real Property Holding Corporation" as
defined in the Code and applicable Treasury regulations thereunder.

         SECTION 3.13. Insurance Coverage. The Company has insurance policies
and fidelity bonds covering its assets, business, equipment, properties,
operations, employees, officers and directors of the type and in amounts
customarily carried by Persons conducting businesses similar to those of the
Company and the Subsidiaries. All premiums due and payable under all such
policies and bonds have been paid, and the Company and the Subsidiaries are
otherwise in full compliance with the terms and conditions of all such policies
and bonds, except where the failure to have made payment or to be in full
compliance would not reasonably be expected to result in a Material Adverse
Effect.

         SECTION 3.14. Compliance with Laws. Neither the Company nor any of the
Subsidiaries is in violation of, or has since the Balance Sheet Date violated,

                                       13
<PAGE>   19

any applicable provisions of any laws, statutes, ordinances, regulations,
administrative interpretations, orders, judgments, policies or decrees of any
court or governmental or administrative authority that are applicable to the
Company, any of the Subsidiaries or their respective properties, other than
violations which do not have and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. The Company and the
Subsidiaries have all permits, licenses, certificates of authority, orders and
approvals of, and have made all filings, applications and registrations with
federal, state, local or foreign governmental or regulatory bodies that are
required in order to permit them to carry on their business substantially as
presently conducted, except for such permits, licenses, certificates of
authority, orders, appraisals, filings, applications or registrations the
failure so to have or to make would not reasonably be expected to have a
Material Adverse Effect. All such permits, licenses, certificates of authority,
orders and approvals are in full force and effect, and, to the knowledge of the
Company, no suspension or cancellation of any of them is threatened, and all
such filings, applications and registrations are current in all material
respects, except for such filings, applications and registrations which the
failure to have would not, individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect.

         SECTION 3.15. Transactions with Affiliates. Except as set forth on
Schedule 3.15, no director or officer of the Company, or member of the family of
any such person, or any corporation, partnership, trust or other entity in which
any such person, or any member of the family of any such person, has a
substantial interest or is an officer, director, trustee, partner or holder of
more than 5% of the outstanding capital stock thereof, is a party to any
transaction with the Company or any Subsidiary, including any contract,
agreement or other arrangement providing for the employment of, furnishing of
services by, rental of real or personal property from or otherwise requiring
payments to any such person or firm, other than employment-at-will arrangements
or stock option agreements entered into in the ordinary course of business.

         SECTION 3.16. Finders' Fees. There is no investment banker, broker,
finder or other intermediary which has been retained by or is authorized to act
on behalf of the Company or any Subsidiary who might be entitled to any fee or
commission from the Investors, the Company or any of their respective Affiliates
upon consummation of the transactions contemplated by this Agreement.

         SECTION 3.17. Antitakeover Statutes. The Company has taken all action
necessary to exempt the Transaction Agreements and the purchase of the
Securities or the transactions contemplated thereby from Section 1701.831 of the
Ohio Revised Code, and, accordingly, neither such Section nor any other
antitakeover or similar statute or regulation applies or purports to apply to
any such transactions. No other "control share acquisition," "fair price,"
"moratorium" or other antitakeover laws or regulations enacted under U.S. state
or

                                       14
<PAGE>   20

federal laws apply to the Transaction Agreements and the purchase of the
Securities or any of the transactions contemplated thereby.

                                   ARTICLE IV
                   REPRESENTATIONS AND WARRANTIES OF INVESTORS

         Each Investor hereby represents and warrants to the Company that:

         SECTION 4.01. Organization and Existence. Investor is a limited
partnership duly organized, validly existing and in good standing under the laws
of its jurisdiction of incorporation and has all powers and all material
governmental licenses, authorizations, consents and approvals required to carry
on its business as now conducted.

         SECTION 4.02. Authorization. The execution, delivery and performance by
Investor of the Transaction Agreements and the consummation by Investor of the
transactions contemplated thereby are within the powers of Investor and have
been duly authorized by all necessary action on the part of Investor. This
Agreement constitutes, and as of Closing the Investor Rights Agreement will
constitute, a valid and binding agreement of Investor, enforceable against
Investor in accordance with their respective terms, except for the
Enforceability Exceptions.

         SECTION 4.03. Governmental Authorization. The execution, delivery and
performance by Investor of the Transaction Agreements require no action by or in
respect of, or filing with, any governmental body, agency, official or authority
other than compliance with any applicable requirements of the 1933 Act and
applicable state securities laws.

         SECTION 4.04. Non-contravention. The execution, delivery and
performance by Investor of the Transaction Agreements do not and will not (i)
contravene or conflict with its agreement of limited partnership (ii) assuming
compliance with the matters referred to in Section 4.03, contravene or conflict
with or constitute a violation of any provision of any law, regulation,
judgment, injunction, order or decree binding upon or applicable to Investor or
(iii) contravene any agreement, contract or other instrument of Investor,
except, in the case of those items specified in (ii) or (iii) above which would
not, individually or in the aggregate, either result in a material adverse
effect on the assets or financial condition of Investor and its subsidiaries,
taken as a whole, or entitle any party to challenge or hinder the transactions
contemplated hereby.

         SECTION 4.05. Finders' Fees. There is no investment banker, broker,
finder or other intermediary which has been retained by or is authorized to act
on

                                       15
<PAGE>   21

behalf of Investor who might be entitled to any fee or commission from Investor,
the Company or any of their respective Affiliates upon consummation of the
transactions contemplated by this Agreement.

         SECTION 4.06. Financing. Investor will have at Closing sufficient funds
available to purchase the Securities allocated to it.

         SECTION 4.07.  Purchase for Investment.  (a) Investor is an "accredited
investor" within the meaning of Rule 501 under the 1933 Act and Investor was
not organized for the specific purpose of acquiring the Securities;

         (b) Investor has sufficient knowledge and experience in investing in
companies similar to the Company so as to be able to evaluate the risks and
merits of its investment in the Company and Investor is able financially to bear
the risks thereof;

         (c) Investor has had an opportunity to discuss the Company's business,
management and financial affairs with the Company's management and to obtain
whatever information concerning the Company and the Shares as has been requested
by Investor in order to make its investment decision with respect to the Shares;

         (d) the Securities being purchased by Investor are being acquired for
its own account for the purpose of investment and not with a view to or for sale
in connection with any distribution thereof;

         (e) Investor understands that (i) the Securities have not been
registered under the 1933 Act and are being sold and issued to Investor in
reliance upon an exemption from the registration requirements of the 1933 Act
pursuant to Section 4(2) thereof or Rule 506 promulgated under the 1933 Act and
under applicable state securities laws, (ii) the Securities must be held
indefinitely unless a subsequent disposition thereof is registered under the
1933 Act and under applicable state securities laws or is exempt from such
registration, (iii) the Securities will bear a legend to such effect, and (iv)
the Company will make a notation on its transfer books to such effect.

                                    ARTICLE V
                            COVENANTS OF THE COMPANY

         The Company agrees that:

         SECTION 5.01. Access to Information. From the date hereof until the
Closing Date, the Company (a) will give, and will cause each Subsidiary to give,

                                       16
<PAGE>   22

the Investors, their counsel, financial advisors, auditors and other authorized
representatives reasonable access to the offices, properties, books and records
of the Company and the Subsidiaries, (b) will furnish, and will cause each
Subsidiary to furnish, to the Investors, their counsel, financial advisors,
auditors and other authorized representatives such financial and operating data
and other information relating to the Company and the Subsidiaries as such
Persons may reasonably request and (c) will instruct the employees, counsel and
financial advisors of the Company and the Subsidiaries to cooperate in all
reasonable respects with the Investors in their investigation of the Company and
the Subsidiaries; provided that no investigation pursuant to this Section shall
affect any representation or warranty given by the Company hereunder.
Notwithstanding the foregoing, the Investors shall not have access to personnel
records of the Company or any Subsidiary relating to individual performance or
evaluation records, medical histories or other information which in the
Company's good faith opinion is sensitive or the disclosure of which could
subject the Company to risk of liability.

         SECTION 5.02.  Notices of Certain Events.  The Company shall promptly
notify Investors of:

                  (i) any notice or other communication from any Person alleging
         that the consent of such Person is or may be required in connection
         with the transactions contemplated by this Agreement;

                  (ii) any notice or other communication from any governmental
         or regulatory agency or authority in connection with the transactions
         contemplated by this Agreement; and

                  (iii) any actions, suits, claims, investigations or
         proceedings commenced or, to the Company's knowledge, threatened
         against, relating to or involving or otherwise affecting the Company or
         any Subsidiary that, if pending on the date of this Agreement, would
         have been required to have been disclosed pursuant to Sections 3.09 or
         3.12 or that relate to the consummation of the transactions
         contemplated by this Agreement.

         SECTION 5.03. Use of Proceeds. The Company shall use the proceeds from
the sale of the Securities solely for (i) working capital (including, without
limitation, acquisitions of other businesses and/or technologies), (ii) the
Company's Frontstep initiative, and (iii) general business purposes.

         SECTION 5.04. Corporate Governing Documents. The Company shall at all
times maintain provisions in its code of regulations and/or articles of
incorporation indemnifying all directors and officers against liability and
absolving all directors and officers from liability to the Company and its
shareholders to the maximum extent permitted under the laws of the State of
Ohio.

                                       17
<PAGE>   23

         SECTION 5.05. Restrictive Agreements Prohibited. The Company shall not
become a party to any agreement which by its terms restricts the Company's
performance of any of the Transaction Agreements, the Warrants or the Company's
Amended Articles of Incorporation, as amended.

         SECTION 5.06. Voting Power. The Company shall use its reasonable best
efforts to amend its Amended Articles of Incorporation, as amended, at the next
annual meeting of the Company's shareholders and to take such other action in
accordance with Ohio law as required to allow the shares of any series of
preferred shares currently outstanding or designated in the future by action of
the Board of Directors to have the right to more than one vote per share,
including amending the Company's Amended Articles of Incorporation, as amended,
relating to the Series A Preferred Shares.

         SECTION 5.07. Additional Warrants. If the Company, by dividend to
holders of the Common Shares, transfers ownership of all or a part of any
Subsidiary to shareholders of the Company, then promptly after the effective
date of such dividend the Company shall issue to the holders of any Warrants
then outstanding subsequent to such dividend additional warrants to purchase
common shares in such Subsidiary having substantially the same terms and
conditions as the Warrants except as provided in this Section 5.07. The number
of common shares of such Subsidiary covered by the additional warrants issued to
each such holder shall be sufficient to give the holder the same percentage
ownership in the outstanding common shares (calculated on a fully diluted basis)
of the Subsidiary that such holder has in the outstanding Common Shares
(calculated on a fully diluted basis) under the Warrants as of the effective
date of the dividend. The exercise price of each such additional warrant shall
be a dollar amount determined by dividing (1) the product of the Exercise Price
of a Warrant immediately prior to the public announcement multiplied by the
Daily Price per common share of the Subsidiary immediately after such dividend
by (2) the Current Market Price per Common Share immediately prior to the public
announcement of such dividend. For purposes hereof, the terms Exercise Price,
Daily Price and Current Market Price per Common Share shall be as such terms are
defined in the Warrant.

                                   ARTICLE VI
                             COVENANTS OF INVESTORS

         Each Investor agrees that:

         SECTION 6.01. Notices of Certain Events. Investor shall promptly notify
the Company of:

                                       18
<PAGE>   24

                  (i) any notice or other communication from any Person alleging
         that the consent of such Person is or may be required in connection
         with the transactions contemplated by this Agreement;

                  (ii) any notice or other communication from any governmental
         or regulatory agency or authority in connection with the transactions
         contemplated by this Agreement; and

                  (iii) any actions, suits, claims, investigations or
         proceedings commenced or, to its knowledge threatened against, relating
         to or involving or otherwise affecting Investor that relate to the
         consummation of the transactions contemplated by this Agreement.

         SECTION 6.02. Confidentiality. Investors shall keep confidential any
information (unless readily ascertainable from public information sources,
otherwise required by law to be disclosed or necessary in connection with any
litigation among the parties hereto) obtained from the Company and/or the
Subsidiaries in connection with the transactions contemplated by the Transaction
Agreements. The confidentiality obligations of Investors shall not be construed
to prevent an Investor from disclosing information concerning the Company and
the Subsidiaries, the Transaction Agreements or the Shares to its respective
employees, officers, directors, partners (general and limited), counsel,
accountants, professional advisors and regulatory authorities if the Investor
making such disclosure takes reasonable measures to ensure that such
confidential information is not misused by the recipients thereof and the
recipients otherwise abide by the restrictions on disclosure imposed on the
Investor hereunder as if such restrictions were imposed directly on the
recipients.

                                   ARTICLE VII
                            COVENANTS OF ALL PARTIES

         The parties hereto agree that:

         SECTION 7.01. Best Efforts. Subject to the terms and conditions of this
Agreement, each party will use its reasonable best efforts to take, or cause to
be taken, all actions and to do, or cause to be done, all things necessary or
desirable under applicable laws and regulations to satisfy all conditions to
Closing set forth in Article VIII of this Agreement applicable to such party and
to consummate the transactions contemplated by this Agreement. The Company and
each Investor agree to execute and deliver such other documents, certificates,
agreements and other writings and to take such other actions as may be necessary
or desirable in order to consummate or implement expeditiously the transactions
contemplated by this Agreement.

                                       19
<PAGE>   25

         SECTION 7.02. Certain Filings; NASDAQ listing. The Company and the
Investors shall cooperate with one another (a) in determining whether any
actions, consents, approvals or waivers are required to be obtained from parties
to any material contracts, in connection with the consummation of the
transactions contemplated by this Agreement, (b) in taking such actions or
making any such filings, furnishing information required in connection therewith
and seeking timely to obtain any such actions, consents, approvals or waivers,
and (c) in causing the Common Shares underlying the Securities to be listed on
the NASDAQ Stock Market in accordance with the rules and regulations of the
NASDAQ Stock Market.

         SECTION 7.03. Public Announcements. The parties agree to consult with
each other before issuing any press release or making any public statement with
respect to this Agreement or the transactions contemplated hereby and, except as
may be required by applicable law or any listing agreement with any national
securities exchange, will not issue any such press release or make any such
public statement prior to such consultation.

         SECTION 7.04. Tax Consistency. The Company and the Investors confirm
that the Series A Preferred Shares are intended to be "common stock" for
purposes of the Code and agree not to take voluntarily any action inconsistent
with such intention.

                                  ARTICLE VIII
                              CONDITIONS TO CLOSING

         SECTION 8.01. Conditions to the Obligations of Each Party. The several
obligations of the Investors and the Company to consummate the Closing are
subject to the satisfaction of the following conditions:

          (a) No provision of any applicable law or regulation and no judgment,
injunction, order or decree shall prohibit the consummation of the Closing; and

          (b) No proceeding challenging this Agreement or the transactions
contemplated hereby or seeking to prohibit, alter, prevent or materially delay
the Closing shall have been instituted by any governmental body, agency,
official or authority before any court, arbitrator or governmental body, agency
or official and be pending.

         SECTION 8.02. Conditions to Obligation of Investors. The obligations of
the Investors to consummate the Closing are subject to the satisfaction of the
following further conditions:

                                       20
<PAGE>   26

          (a) (i) the Company shall have performed in all material respects all
of its obligations hereunder required to be performed by it on or prior to the
Closing Date, (ii) the representations and warranties of the Company contained
in this Agreement and in any certificate or other writing delivered by the
Company pursuant hereto shall be true in all material respects at and as of the
Closing Date, as if made at and as of such date (except for such that refer to
an earlier date) and (iii) Investors shall have received a certificate signed by
an executive officer of the Company to the foregoing effect;

          (b)   The Investors Rights Agreement shall have been executed and
delivered by the Company, the Investors and Lawrence J. Fox;

          (c) The Amendment shall have been filed with the Secretary of State of
the State of Ohio and shall read in its entirety as set forth in Exhibit A;

          (d) The number of directors constituting the entire Board of Directors
shall have been fixed at no greater than nine (9) and the following persons
shall have been elected as directors and shall hold such position as of the
Closing Date: Guy de Chazal and Barry Goldsmith.

          (e) Investor shall have received an opinion of Vorys, Sater, Seymour
and Pease LLP, counsel to the Company, dated the Closing Date in reasonable and
customary form. In rendering such opinions, counsel may rely upon certificates
of public officials, and as to matters of fact, upon certificates of officers of
the Company and the Subsidiaries;

          (f) Investors shall have received all documents it may reasonably
request relating to the existence of the Company and the Subsidiaries and the
authority of the Company to execute and perform this Agreement, all in form and
substance reasonably satisfactory to the Investors.

         SECTION 8.03. Conditions to Obligation of the Company. The obligation
of the Company to consummate the Closing is subject to the satisfaction of the
following further conditions:

          (a) (i) Investors shall have performed in all material respects all of
its obligations hereunder required to be performed by them at or prior to the
Closing Date, and (ii) the representations and warranties of the Investors
contained in this Agreement and in any certificate or other writing delivered by
Investors pursuant hereto shall be true in all material respects at and as of
the Closing Date, as if made at and as of such date (except for such that refer
to an earlier date);

          (b)   Each Investor shall have signed the Investor Rights Agreement.

                                       21
<PAGE>   27

          (c) The Amendment and the Transaction Agreements (and the transactions
contemplated thereby) shall have been approved by the Board of Directors of the
Company.

                                   ARTICLE IX
                                    SURVIVAL

         SECTION 9.01. Survival. The covenants, agreements, representations and
warranties of the parties hereto contained in this Agreement or in any
certificate or other writing delivered pursuant hereto or in connection herewith
shall survive the Closing. The representations and warranties of the parties
hereto contained in this Agreement shall be deemed made only as of the date
hereof and as of the Closing Date, in each case unless a different date is
specified in the representation and warranty.

                                    ARTICLE X
                                   TERMINATION

         SECTION 10.01. Grounds for Termination. This Agreement shall terminate
upon either party giving notice of the termination of this Agreement as a result
of the occurrence of any of the following:

         (a) by mutual written agreement of the Company and Investors having
75% or more of the total commitment to purchase the Securities;

         (b) if the Closing shall not have been consummated on or before May 31,
2000; or

         (c) prior to Closing if after the date hereof there shall be any law or
regulation enacted or promulgated that makes consummation of the transactions
contemplated hereby illegal or otherwise prohibited or if consummation of the
transactions contemplated hereby would violate any nonappealable final order,
decree or judgment of any court or governmental body having competent
jurisdiction;

         The party desiring to terminate this Agreement pursuant to this Section
10.01 shall give notice of such termination to the other party.

         SECTION 10.02. Effect of Termination. If this Agreement is terminated
as permitted by Section 10.01, such termination shall be without liability of
either party (or any shareholder, director, officer, employee, agent, consultant
or representative of such party) to the other party to this Agreement; provided
that if such termination shall result from the willful failure of either party
to fulfill a

                                       22
<PAGE>   28

condition to the performance of the obligations of the other party or to perform
a covenant of this Agreement or from a willful breach by either party to this
Agreement, such party shall be fully liable for any and all damages incurred or
suffered by the other party as a result of such failure or breach. The
provisions of Sections 6.02, 7.03, 10.02, 11.03 and 11.05 shall survive any
termination hereof pursuant to Section 10.01.

                                   ARTICLE XI
                                  MISCELLANEOUS

         SECTION 11.01. Notices. All notices, requests and other communications
to either party hereunder shall be in writing (including telecopy or similar
writing) and shall be given,

         if to the Company, to:

                           Symix Systems, Inc.
                           2800 Corporate Exchange Drive
                           Columbus, Ohio  43231
                           Attention: Corporate Counsel
                           Telecopy: (614) 895-2972

                           with a copy to:

                           Ivery D. Foreman, Esq.
                           Vorys, Sater, Seymour and Pease LLP
                           52 East Gay Street
                           Columbus, Ohio 43216-1008
                           Telecopy: (614) 464-6350

if to an Investor, to its address set forth on the signature pages hereto:

                           with copies to:

                           John A. Bick, Esq.
                           Davis Polk & Wardwell
                           450 Lexington Ave.
                           New York, New York 10017
                           Telecopy: (212) 450-4800

         SECTION 11.02.  Amendments; No Waivers.  (a) Any provision of this
Agreement may be amended or waived if, and only if, such amendment or waiver
is in writing and signed, in the case of an amendment, by each Investor and the

                                       23
<PAGE>   29

Company, or in the case of a waiver, by the party against whom the waiver is to
be effective.

          (b) No failure or delay by either party in exercising any right, power
or privilege hereunder shall operate as a waiver thereof nor shall any single or
partial exercise thereof preclude any other or further exercise thereof or the
exercise of any other right, power or privilege. The rights and remedies herein
provided shall be cumulative and not exclusive of any rights or remedies
provided by law.

         SECTION 11.03. Expenses. All costs and expenses incurred in connection
with this Agreement shall be paid by the party incurring such cost or expense;
provided that the Company shall reimburse the Investors for their out-of-pocket
fees and expenses, including the fees and expenses of Davis Polk & Wardwell, up
to an aggregate amount not to exceed $150,000.

         SECTION 11.04. Successors and Assigns. The provisions of this Agreement
shall be binding upon and inure to the benefit of the parties hereto and their
respective successors and permitted assigns; provided that no party may assign,
delegate or otherwise transfer any of its rights or obligations under this
Agreement without the consent of the other parties hereto.

         SECTION 11.05.  Governing Law.  This Agreement shall be construed in
accordance with and governed by the internal laws of the State of Ohio.

         SECTION 11.06. Counterparts. This Agreement may be signed in any number
of counterparts, each of which shall be an original, with the same effect as if
the signatures thereto and hereto were upon the same instrument.

         SECTION 11.07. Entire Agreement. The Transaction Agreements and the
Warrants constitute the entire agreement between the parties with respect to the
subject matter hereof (other than a writing which specifically states that it
shall not be subject to this Section 11.07) and supersede all prior agreements,
understandings and negotiations, both written and oral, between the parties with
respect to the subject matter of the Transaction Agreements and the Warrants
(other than a writing which specifically states that it shall not be subject to
this Section 11.07). No representation, inducement, promise, understanding,
condition or warranty not set forth herein has been made or relied upon by any
party hereto. Neither this Agreement nor any provision hereof is intended to
confer upon any Person other than the parties hereto any rights or remedies
hereunder.

         SECTION 11.08. Specific Performance. Each of the parties hereto agrees
that any breach by it of any provision of this Agreement would irreparably
injure the other party and that money damages would be an inadequate remedy
therefor. Accordingly, each of the parties hereto agrees that the other party
shall be entitled

                                       24
<PAGE>   30

to one or more injunctions enjoining any such breach or requiring specific
performance of this Agreement and consents to the entry thereof, this being in
addition to any other remedy to which the non-breaching party is entitled at law
or in equity.

         SECTION 11.09.  Captions.  The captions herein are included for
convenience of reference only and shall be ignored in the construction or
interpretation hereof.

                                       25
<PAGE>   31

         IN WITNESS WHEREOF, the parties hereto here caused this Agreement to be
duly executed by their respective authorized officers as of the day and year
first above written.

                                      SYMIX SYSTEMS, INC.

                                      By/s/Stephen A. Sasser
                                        -------------------------------------
                                        Stephen A. Sasser
                                        President and Chief Executive Officer

INVESTORS:

MORGAN STANLEY DEAN WITTER VENTURE PARTNERS IV, L.P.
MORGAN STANLEY DEAN WITTER VENTURE INVESTORS  IV, L.P.
MORGAN STANLEY DEAN WITTER VENTURE OFFSHORE
INVESTORS IV, L.P.

By: MSDW Venture Partners IV, L.L.C.
        as General Partner of the above limited partnerships
By: MSDW Venture Capital IV, Inc.,
        as Member

By:/s/Guy de Chazal
   ----------------------------------
   Name:     Guy de Chazal
   Title:    Managing Director

Address:        1221 Avenue of the Americas
                New York, New York 10020
                Fax: 212-762-8424

MORGAN STANLEY DEAN WITTER
    EQUITY FUNDING, INC.

By:/s/Thomas Clayton
   -----------------------------------
   Name:Thomas Clayton
   Title:Vice President

Address:        1221 Avenue of the Americas
                New York, New York 10020
                Fax: 212-762-8424
                Attention: Controller

                                       26
<PAGE>   32

FALLEN ANGEL EQUITY FUND, L.P.

By:      Fallen Angel Capital, L.L.C.
         as its General Partner
By:      Barry Goldsmith,
         as Member

By: /s/Barry Goldsmith
    -----------------------------
Name:    Barry Goldsmith
Title:   Member

Address:     960 Holmdel Road
             Holmdel, New Jersey 07733
             Fax: 732-946-0519

                                       27
<PAGE>   33

                                   SCHEDULE I
                                   ----------

                                    INVESTORS
                                    ---------

<TABLE>
<CAPTION>

                                                        Number of                            Aggregate
                                                        Preferred          Number of       Purchase Price
                                                          Shares            Warrants          for All
Name and Address of Investor                         to be Purchased    to be Purchased      Securities

<S>                                                     <C>                <C>             <C>
(a)  Morgan Stanley Dean Witter Venture                   271,650            217,320         $6,585,456
     Partners IV, L.P.
(b)  Morgan Stanley Dean Witter Venture                    31,516             25,212           $764,016
     Investors IV, L.P.
(c)  Morgan Stanley Dean Witter Venture                    10,598              8,478           $256,920
     Offshore Investors, L.P.
(d)  Morgan Stanley Dean Witter Equity                     86,502             69,202         $1,999,992
     Funding, Inc.
(d)  Fallen Angel Equity Fund, L.P.                       166,667            133,334         $4,000,008
Totals                                                    566,933            453,546        $13,606,392
</TABLE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00009-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00009-of-00352.parquet"}]]